title: [Effects of Losartan on expression of heme oxygenases in volume-overloaded rats with left-to-right shunt].
abstract: OBJECTIVE
  To study the expression of heme oxygenase-1 mRNA and pulmonary remodeling before and after surgical establishment of left-to-right shunt in volume-overloaded SD rats and rats with Losartan intervention.
  
  
  METHODS
  Left-to-right shunt volume-overloaded SD rat models were established by aortocaval shunt operation. Seven rats with shunt were placed on Losartan (Losartan group), 7 rats with but not given Losartan were included in the operation group, and 4 rats after sham operation served as controls. Pulmonary pressure and right ventricular pressure were measured during catheterization. The relative weights ventricles were determined after execution of the rats. Pulmonary vascular remodeling parameters, including percentage arterial wall thickness and percentage muscularized small arteries, were assessed by morphometry. Heme oxygenase-1 (HO-1) mRNA expression and heme oxygenase-2 (HO-2) mRNA expression were detected RT-PCR method.
  
  
  RESULTS
  Pulmonary artery pressure and right ventricular relative weight decreased significantly in the rats of Losartan group; in addition, the percentage arterial wall thickness and percentage of muscularized small arteries in the Losartan group were reduced as compared with those in the operation group. The level 1 mRAN expression in rats with shunt was significantly higher than that in rats without shunt. The level mRNA expression in the Losartan group decreased remarkably as compared against that in the operation The level of HO-1 mRNA expression in lungs was significantly higher than that in ventricles. There statistically significant differences in HO-2 mRNA expression levels between the three rat groups.
  
  
  CONCLUSIONS
  Losartan intervention can markedly reduce pulmonary pressure, inhibit vascular remodeling in volume-overloaded left-to-right shunt rats, and result in down-regulation of HO-1 mRNA expression.
authors.affiliation: Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu 610041, China.
authors.forename: Li-Xing
authors.initials: LX
authors.lastname: Yuan
authors.forename: Han-Min
authors.initials: HM
authors.lastname: Liu
authors.forename: Mi
authors.initials: M
authors.lastname: Li
authors.forename: Ju
authors.initials: J
authors.lastname: Gao
authors.forename: Tong-Fu
authors.initials: TF
authors.lastname: Zhou
mesh_terms: D000818:Animals; D001166:Arteriovenous Shunt, Surgical; D015536:Down-Regulation; D005260:Female; D006419:Heme Oxygenase (Decyclizing) / Q000096:biosynthesis / Q000235:genetics; D051547:Heme Oxygenase-1 / Q000096:biosynthesis* / Q000235:genetics; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000378:metabolism*; D019808:Losartan / Q000494:pharmacology*; D008297:Male; D011651:Pulmonary Artery / Q000503:physiopathology*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats
chemical_list: D012333:RNA, Messenger; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1; C105245:heme oxygenase-2; D019808:Losartan